Bridging gaps in mitochondrial disease diagnosis: the role of advanced biomarker discovery

Puntos clave

• Advanced biomarker discovery significantly improves the diagnosis of mitochondrial disease, enhancing clinical outcomes.
• Key evidence indicates that utilizing advanced biomarkers can lead to more accurate diagnosis in cases previously deemed ambiguous.
• Analysis focuses on newly identified biomarkers related to mitochondrial disease pathways and mechanisms for diagnosis.
• Improved diagnostics may enable more effective interventions for mitochondrial diseases; further validation is needed.